|
1
|
SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma.
|
Lancet Oncol
|
2010
|
2.42
|
|
2
|
Clinical predictors for germline mutations in head and neck paraganglioma patients: cost reduction strategy in genetic diagnostic process as fall-out.
|
Cancer Res
|
2009
|
1.53
|
|
3
|
Evidence of MEN-2 in the original description of classic pheochromocytoma.
|
N Engl J Med
|
2007
|
1.24
|
|
4
|
Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas.
|
JAMA
|
2010
|
1.22
|
|
5
|
Extra-adrenal and adrenal pheochromocytomas associated with a germline SDHC mutation.
|
Nat Clin Pract Endocrinol Metab
|
2008
|
1.22
|
|
6
|
Head and neck paragangliomas in von Hippel-Lindau disease and multiple endocrine neoplasia type 2.
|
J Clin Endocrinol Metab
|
2009
|
1.04
|
|
7
|
Expression profiling of T-cell lymphomas differentiates peripheral and lymphoblastic lymphomas and defines survival related genes.
|
Clin Cancer Res
|
2004
|
1.04
|
|
8
|
Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1.
|
J Clin Endocrinol Metab
|
2007
|
1.02
|
|
9
|
Novel pheochromocytoma susceptibility loci identified by integrative genomics.
|
Cancer Res
|
2005
|
1.01
|
|
10
|
Evaluation of a functional epigenetic approach to identify promoter region methylation in phaeochromocytoma and neuroblastoma.
|
Endocr Relat Cancer
|
2008
|
0.85
|
|
11
|
Systematic comparison of sporadic and syndromic pancreatic islet cell tumors.
|
Endocr Relat Cancer
|
2010
|
0.80
|